Plasma microRNA vary in association with the progression of Alzheimer's disease.

Guévremont, Diane; Tsui, Helen; Knight, Robert; Fowler, Chris J; Masters, Colin L; Martins, Ralph N; Abraham, Wickliffe C; Tate, Warren P; Cutfield, Nicholas J; Williams, Joanna M

Guévremont, Diane; Tsui, Helen; Knight, Robert; Fowler, Chris J; Masters, Colin L; Martins, Ralph N; Abraham, Wickliffe C; Tate, Warren P; Cutfield, Nicholas J; Williams, Joanna M.

Afiliación

Guévremont D; Department of Anatomy University of Otago Dunedin New Zealand.
Tsui H; Brain Health Research Centre University of Otago Dunedin New Zealand.
Knight R; Brain Research New Zealand, Rangahau Roro Aotearoa University of Otago Dunedin New Zealand.
Fowler CJ; Brain Health Research Centre University of Otago Dunedin New Zealand.
Masters CL; Brain Research New Zealand, Rangahau Roro Aotearoa University of Otago Dunedin New Zealand.
Martins RN; Department of Psychology University of Otago Dunedin New Zealand.
Abraham WC; Brain Health Research Centre University of Otago Dunedin New Zealand.
Tate WP; Brain Research New Zealand, Rangahau Roro Aotearoa University of Otago Dunedin New Zealand.
Cutfield NJ; Department of Psychology University of Otago Dunedin New Zealand.
Williams JM; The Florey Institute, The University of Melbourne, Parkville, Victoria, Australia. MD The Florey Institute The University of Melbourne Parkville Victoria Australia.

Alzheimers Dement (Amst) ; 14(1): e12251, 2022.

Article en En | MEDLINE | ID: mdl-35141392

Palabras clave

Alzheimer's disease; biomarker; disease progression; early diagnostic; microRNA; plasma

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Alzheimers Dement (Amst) Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google